dorzolamide ophthalmic
Selected indexed studies
- Hypokalemia associated with topical administration of dorzolamide 2% ophthalmic solution in cats. (Vet Ophthalmol, 2021) [PMID:33085174]
- Perianesthetic metabolic acidosis is associated with 2% dorzolamide eye drops in dogs that underwent ophthalmic surgery: a retrospective study (2019-2022). (J Am Vet Med Assoc, 2024) [PMID:38244267]
- Effect of topical ophthalmic dorzolamide(2%)-timolol(0.5%) solution and ointment on intraocular pressure in normal horses. (Vet Ophthalmol, 2015) [PMID:25522663]
_Worker-drafted node — pending editorial review._
Connections
dorzolamide ophthalmic is a side effect of
Sources
- Hypokalemia associated with topical administration of dorzolamide 2% ophthalmic solution in cats. (2021) pubmed
- Perianesthetic metabolic acidosis is associated with 2% dorzolamide eye drops in dogs that underwent ophthalmic surgery: a retrospective study (2019-2022). (2024) pubmed
- Effect of topical ophthalmic dorzolamide(2%)-timolol(0.5%) solution and ointment on intraocular pressure in normal horses. (2015) pubmed
- Clinical pharmacokinetics of dorzolamide. (2002) pubmed
- Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients. (2018) pubmed
- Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. (2009) pubmed
- Efficacy of perioperative 2% dorzolamide ophthalmic solution for reduction of postoperative ocular hypertension in dogs following routine phacoemulsification surgery: A prospective clinical trial. (2025) pubmed
- Netarsudil-related Eyelid Wound Dehiscence. (2021) pubmed
- [Timolol topical ophthalmic combination]. (2004) pubmed
- A one-week comfort study of BID-dosed brinzolamide 1%/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertension. (2008) pubmed